ClinicalTrials.gov
public full text
Public Domain
Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Induction of Clinical Response Using Rifaximin in Crohn's Disease#1075107
- Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease#838580
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease#840785
- Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis#827302
- A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease#1087488
Record · ID 217065
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive